WallStreetZenWallStreetZen

NASDAQ: GLYC
Glycomimetics Inc Stock Forecast, Predictions & Price Target

Analyst price target for GLYC

Based on 1 analyst offering 12 month price targets for Glycomimetics Inc.
Min Forecast
$8.00+396.89%
Avg Forecast
$8.00+396.89%
Max Forecast
$8.00+396.89%

Should I buy or sell GLYC stock?

Based on 1 analyst offering ratings for Glycomimetics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GLYC stock forecasts and price targets.

GLYC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-08-03

1 of 1

Forecast return on equity

Is GLYC forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is GLYC forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

GLYC revenue forecast

What is GLYC's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$23.7M
Avg 2 year Forecast
$12.8M
Avg 3 year Forecast
$26.9M

GLYC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLYC$1.61$8.00+396.89%Buy
INO$0.38N/AN/A
HOWL$2.90$12.00+313.79%Buy
SLDB$5.06$7.00+38.34%Strong Buy
ANVS$10.28$32.50+216.15%Strong Buy

Glycomimetics Stock Forecast FAQ

Is Glycomimetics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GLYC) stock is to Buy GLYC stock.

Out of 1 analyst, 0 (0%) are recommending GLYC as a Strong Buy, 1 (100%) are recommending GLYC as a Buy, 0 (0%) are recommending GLYC as a Hold, 0 (0%) are recommending GLYC as a Sell, and 0 (0%) are recommending GLYC as a Strong Sell.

If you're new to stock investing, here's how to buy Glycomimetics stock.

What is GLYC's revenue growth forecast for 2025-2027?

(NASDAQ: GLYC) Glycomimetics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Glycomimetics's revenue in 2023 is $0.On average, 2 Wall Street analysts forecast GLYC's revenue for 2025 to be $1,526,121,068, with the lowest GLYC revenue forecast at $109,468,600, and the highest GLYC revenue forecast at $2,942,773,536. On average, 1 Wall Street analysts forecast GLYC's revenue for 2026 to be $824,234,163, with the lowest GLYC revenue forecast at $824,234,163, and the highest GLYC revenue forecast at $824,234,163.

In 2027, GLYC is forecast to generate $1,732,179,609 in revenue, with the lowest revenue forecast at $1,732,179,609 and the highest revenue forecast at $1,732,179,609.

What is GLYC's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: GLYC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is GLYC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GLYC price target, the average GLYC price target is $8.00, with the highest GLYC stock price forecast at $8.00 and the lowest GLYC stock price forecast at $8.00.

The Wall Street analyst predicted that Glycomimetics's share price could reach $8.00 by Aug 3, 2024. The average Glycomimetics stock price prediction forecasts a potential upside of 396.89% from the current GLYC share price of $1.61.

What is GLYC's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: GLYC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.